Work

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

Year: 2005

Type: article

Study design: Clinical Trial

Source: Anti-Cancer Drugs

DOI: 10.1097/01.cad.0000176504.86551.5c

Authors: Julian R. Molina, Joel M. Reid, Charles Erlichman, Jeff A. Sloan, Alfred Furth, Stephanie L. Safgren, Chetan D. Lathia, Steven R. Alberts

Institution: Mayo Clinic

Language: English

Topic: Protease and Inhibitor Mechanisms

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2049407173

FWCI: 1.385

Cites: 8

Cited by: 32

Related to: 10